期刊文献+

奥替溴铵对腹泻型肠易激综合征患者肛门直肠感觉运动功能的影响 被引量:2

Effects of otilonium bromide on anorectal visceral sensorimotor functions of patients with diarrhea-predominant irritable bowel syndrome
下载PDF
导出
摘要 目的:探讨奥替溴铵对腹泻型肠易激综合征(D-IBS)患者肛门直肠感觉运动功能的效应.方法:用电子气压泵(barostat)及液流灌注压力监测系统对20例 D-IBS 患者及20名健康人进行肛门直肠测压检查.并对D-IBS 患者用奥替溴铵治疗2wk,再复查肛门直肠测压;治疗前后均对患者行临床症状评分.结果:肛门内括约肌静息压(kPa)、肛门内括约肌最大收缩压(kPa)、最小抑制容量(mL)、直肠顺应性(mL/0.133kPa)在D-IBS 患者与健康人之间无显著性差异(P>0.05);D-IBS 患者的直肠初始感党阈、排便阈、疼痛阈分别为52.6±17.3mL、84.6±34.3mL 及128.6±24.3mL,分别低于健康人的87.3±14.5mL(P<0.05)、128.4±26.5mL(P±0.05)及206.1±36.5mL(P<0.05).奥替溴铵治疗前患者腹痛、腹胀、排便频率、粪便性状及 IBS 总体症状感觉评分分别为1.90±0.72、1.75±0.78、1.85±0.67、1.70±0.73及1.91±0.68,治疗后明显下降,分别为0.70±0.57(P<0.01)、0.55±0.51(P<0.01)、0.65±0.59(P<0.01)、0.75±0.50(P<0.01)、0.65±0.59(P<0.01).与治疗前比较,患者的直肠初始感觉阈、排便阈及疼痛阈均明显升高,分别为79.3±13.2mL(P<0.05)、112.2±23.2 mL(P<0.05)及189.1±33.8 mL(P<0.05).结论:奥替溴铵可改善 D-IBS 患者的直肠内脏高敏感性、并有效地缓解患者的临床症状. AIM:To study the effects of otilonium bromide on rectal visceral sensation and anorectal motility in patients with diarrhea-predominant irritable bowel syndrome(d-IBS). METHODS:Anorectal manometry and rectal visceral per- ception to balloon distention were done in 20 patients with d-IBS and in 20 health subjects(HS)by means of electric barostat and perfusion catheter manometer.Then the pa- tients received otilonium bromide 40mg t.i.d for 2 weeks, and the examinations were repeated.The symptom score of the patients was assessed before and after treatment. RESULTS:The resting pressure of internal anal sphincter, the maximal squeeze pressure,the minimal rectal distention volume that could induce the rectum-ano inhibition reflex and the rectal compliance in the patients with d-IBS were similar to those in HS(P>0.05).The thresholds of the first sensation volume,defecation volume and pain volume of rectum in patients with d-IBS were(52.6±17.3 mL), (84.6±34.3 mL)and(128.6±24.3 mL)respectively,and they were significant lower than those of(87.3±14.5 mL), (128.4±26.5 mL)and(206.1±36.5 mL)in HS(P<0.05). After treatment with otilonium bromide,the thresholds of rectal visceral sensation volume in the above patients with d- IBS were significantly increased to(79.3±13.2 mL)P<0.05, (112.2±23.2 mL)(P<0.05),and(189.1±33.8 mL)(P<0.05) respectively,and patients'symptom scores of IBS were significantly decreased at the same time(P<0.05). CONCLUSION:Otilonium bromide can improve rectal visceral: hypersensitivity,and alleviate effectively the symptoms in patients with d-IBS.
出处 《世界华人消化杂志》 CAS 2003年第12期1926-1928,共3页 World Chinese Journal of Digestology
基金 广东省自然科学基金资助项目 No.20001342
  • 相关文献

参考文献4

二级参考文献17

  • 1李爱萍,程留芳,郭荣斌,杨德利.肛门直肠运动协调性障碍与慢性特发性便秘的关系[J].世界华人消化杂志,2000,8(z1). 被引量:3
  • 2Thompson WG. C. Functional bowel disorders and D. Functionalabdominal pain. In: Drossman DA, Corazziari E, Jalley NJ, eds.Functional gastrointestinal disorders: Rome Ⅱ. 1st ed. Mclean,Virginia: Dgnon and Associates, 2000:360-382.
  • 3Corazza GR, Vaira S, Milletti S, et al. Controlled clinical evaluationof pinsverium bromide and trimebutine in functional disorders of thecolon. Acta Ther, 1983,9:383-389.
  • 4Malysz J, Farraway LA, Christen MO, et al. Pinaverium acts as Ltype calcium channel blocker on smooth muscle of colon. Can JPhysiol Pharmacol, 1997,75:969-975.
  • 5Wittmann T, Feher A, Rosztoczy A, et al. Effectiveness ofpinaverium bromide therapy on colonic motility disorders in irritablebowel syndrome. Orv Hetil, 1999,140: 469-473.
  • 6Galeone M, Stock F, Moise G, et al. Pinaverium bromide versusotilonium bromide in patients with irritable bowel syndrome. CurrThe Res, 1986,39:613-624.
  • 7Froguel E, Chaussade S, Roche H, et al. Effects of an intestinalsmooth muscle calcium channal blocker (pinaverium bromide) oncolonic transit time in humans. J Gastrointest Motil, 1990,2: 176-179.
  • 8Guslandi M. The clinical pharmacological profile of pinaverium bromide. Minerva Med, 1994,85:179-185.
  • 9Fioramonti J, Christen MO, Dupre I, et al. Effect of a selectivecalcium antagonist, pinaverium bromide, on sensitivity to rectal distention in experimental inflammation in rats. Gastroenterology,1997,112(suppl): A731.
  • 10杨云生,张万岱,潘德寿,周殿元,宋于刚.肠易激综合征血浆及乙状结肠粘膜中CCK及SP的含量[J].新消化病学杂志,1997,5(7):437-438. 被引量:34

共引文献91

同被引文献5

  • 1GHELARDONI M, RUSSO F, PISANTI N,et al. p-(2-Alkyloxybenzoyl) -aminobenzoates of n-dialkylamine-alkyl and their quaternary salts : US,3536723 [ P]. 1970 - 10 - 27
  • 2GHELARDONI M, PESTELLINI V, PISANTI N ,et al. Quaternary salte of substituted 2-aminoethyl N-benzoylaminobenzoate. A new class of smooth muscle relaxant agents [ J ]. J Med Chem, 1973,16 (9) :1063 - 1065.
  • 3中国药典[S].2010年版.二部.附录ⅨJ.
  • 4郭佳,张永明,赵滟萍,熊涛,丁聪,李宗桃.奥替溴铵的合成研究[J].中国药物化学杂志,2008,18(5):358-361. 被引量:1
  • 5袁耀宗,许斌,柯美云,刘玉兰,傅亮,李兆申,莫剑忠,陈旻湖.奥替溴铵治疗肠易激综合征有效性和安全性的研究[J].胃肠病学,2003,8(5):279-282. 被引量:15

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部